IntroductionPolymorphonuclear neutrophil granulocytes (PMNs or neutrophils) develop in the bone marrow (BM). They are fully equipped with a variety of granules, which contain proteases that enable the neutrophils to deliver lethal hits against invading microorganisms. 1,2 Although neutrophils are essential to host defense against intruding microorganisms and play a critical role in initiating inflammation and innate immunity, they also contribute to the pathology of various acute and chronic inflammatory conditions. 3,4 In this manner, means to properly control the development, homeostasis, and functional activities of neutrophils is of central importance to mounting robust host defense responses and simultaneously avoiding tissue damage. 5,6 However, the molecular mechanisms that accomplish this balanced effect remain poorly understood.Wild-type (WT) p53-induced phosphatase 1 (Wip1, also called PP2C␦), which is encoded by protein phophatase magnesiumdependent 1delta (PPm1D), is a serine/threonine protein phosphatase belonging to the type 2C␦ protein phosphatases. 7 It is activated by various stresses and involved in various cellular processes, such as tumorigenesis and aging. 8,9 Wip1, overexpressed in many cancers, is recognized as a novel oncogene inhibiting several p53-dependent tumor suppressor pathways, such as ATM-CHK2-p53 and p38 MAPK-p53 pathways as well as the NF-B pathway. [10][11][12][13] Currently, Wip1 is thought to be a promising drug target for cancer therapy. In the present study, after observing that Wip1 is specifically expressed in resting neutrophils among all immune cells and is up-regulated gradually during neutrophil maturation, we used Wip1-deficient mice to investigate the role of Wip1 in neutrophil development and homeostasis. Notably, Wip1-deficient mice displayed neutrophilia with significantly expanded granulocytic differentiation and hypermaturation phenotype in a cell-intrinsic and specific manner. Thus, phosphatase Wip1, as a key feedback regulator, negatively controls granulocytopoiesis and peripheral neutrophil homeostasis. Methods MiceC57BL/6 and CD45.1 ϩ mice were purchased from Beijing University Experimental Animal Center (Beijing, China). Wip1 Ϫ/Ϫ , p53 ϩ/Ϫ , and p38 ϩ/Ϫ mice were kindly provided by the Key Laboratory of Human Diseases Comparative Medicine, the Ministry of Public Health (Beijing, China). Wip1 Ϫ/Ϫ mice have been described 10,14 and backcrossed to the C57BL/6 background in our laboratory. Wip1 Ϫ/Ϫ and p53 ϩ/Ϫ mice were mated to obtain Wip1 Ϫ/Ϫ p53 Ϫ/Ϫ double-knockout mice. All mice were bred and maintained in specific pathogen-free conditions. Sex-matched littermate mice 6-12 weeks of age were mainly used for experiments unless otherwise noted. Complete or mixed chimeras were generated by transferring 1 to 2 ϫ 10 7 BM cells (BMCs) from either WT and/or Wip1KO mice into lethally irradiated mice. 15,16 Animal protocols were approved by the Animal Ethics Committee of the Institute of Zoology, Beijing, China. *G.L., X.H., and B.S. contributed equally to this st...
The lymphocyte-monocyte ratio (LMR) is a systemic inflammatory marker for prediction of disease development, progress, and survival. Recently, a genome-wide association study identified genetic variations in ITGA4 and HLA-DRB1 that affect the LMR levels and were widely believed to be susceptibility genes for autoimmune diseases, including rheumatoid arthritis (RA). However, the role of LMR in RA patients remains unclear. The LMR level and other laboratory data of 66 RA patients, 163 osteoarthritis (OA) patients, and 131 healthy controls (HC) were compared using binary logistic regression. The correlations between LMR and disease activity and other inflammatory markers were measured using the Spearman rank test. ROC curve analyses assessed the diagnostic accuracy of LMR in RA. The LMR and lymphocyte count were significantly lower in RA patients, whereas the monocyte count was significantly higher relative to the HC group/OA patients (p < 0.01). A decreased LMR has been associated with increased disease activity (p = 0.012). In addition, the DAS28 and traditional inflammatory markers, including ESR, CRP, RDW, PLR, and NLR, and immune-related factors, such as C4, IgA, and IgM, were inversely correlated with LMR, while hemoglobin and albumin were positively correlated with LMR. The ROC curve showed that the area under the curve of LMR was 0.705 (95%CI = 0.630-0.781). The corresponding specificity and sensitivity were 82.82 and 45.45%, respectively. The present study shows that the LMR is an important inflammatory marker which could be used to identify disease activity in RA patients and to distinguish RA from OA patients.
Neutrophils are critically involved in host defense and tissue damage. Intrinsic signal mechanisms controlling neutrophil activities are poorly defined. We found that the expression of wild-type p53-induced phosphatase 1 (Wip1) in mouse and human neutrophils was downregulated quickly after neutrophil activation through JNK-microRNA-16 pathway. Importantly, the Wip1 expression level was negatively correlated with inflammatory cytokine productions of neutrophils in sepsis patients. Wip1-deficient mice displayed increased bactericidal activities to Staphylococcus aureus and were hypersensitive to LPS-induced acute lung damage with increased neutrophil infiltration and inflammation. Mechanism studies showed that the enhanced inflammatory activity of neutrophils caused by Wip1 deficiency was mediated by p38 MAPK-STAT1 and NF-κB pathways. The increased migration ability of Wip1KO neutrophils was mediated by the decreased CXCR2 internalization and desensitization, which was directly regulated by p38 MAPK activity. Thus, our findings identify a previously unrecognized function of Wip1 as an intrinsic negative regulator for neutrophil proinflammatory cytokine production and migration through multiple signal pathways.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.